IP

International Paper is a scale leader in corrugated packaging, benefiting from sticky customer relationships and a broad mill/box footprint, but it still operates in a cyclical, price-competitive industry where volume and input costs can swing results quickly. The April 16, 2026 agreement to buy NORPAC for $360M signals management is leaning into North American packaging strength and asset positioning, though integration and end-market demand remain swing factors. The story is increasingly about execution on simplification and cost-out rather than organic growth.

Recent results highlight volatility: Q4 2025 EPS was -$0.08, alongside large non-cash and restructuring items, underscoring how reported earnings can be noisy for now. Management guided 2026 enterprise net sales of $24.1B–$24.9B and adjusted EBITDA of $3.5B–$3.7B (with Q1 2026 adjusted EBITDA outlook of $740M–$760M), implying a meaningful step-up if pricing and productivity hold. Balance sheet leverage looks material with cash around $1.16B versus long-term debt about $9.18B (year-end 2025), so the equity remains sensitive to rates, spreads, and any downturn.

Thesis: IP is a turnaround/cycle-recovery packaging name where upside depends on delivering the 2026 EBITDA ramp and proving free-cash-flow durability. Key 12-month catalysts are Q1 2026 earnings on April 30, 2026, early evidence of pricing/volume stabilization, and clearer synergy/portfolio actions including NORPAC integration progress. The key risks are weaker box demand, cost inflation, and leverage constraining flexibility if results miss the EBITDA guide.

Recommendation: HOLD. The risk/reward looks balanced because guidance implies recovery, but leverage and earnings noise mean investors likely need proof of execution and cash generation before paying up.